Fundraising Fox

Dominic Schmidt

Investor

General Partner at Advent Life Sciences

London

Writes $25K – $5M checks · typically $1M

About

Dominic Schmidt joined Advent Life Sciences in April 2022, with a background in biochemistry, genomics, molecular oncology, strategy consulting, and life science venture capital. He previously spent eight years as a Partner on the investment team at Syncona, a publicly listed healthcare investment company, where he helped found and grow several life science businesses. He holds a Diplom in Biochemistry from the Free University of Berlin and the Max Planck Institute for Molecular Genetics, and a PhD in Oncology from the University of Cambridge.

Invests in

BiotechLongevity

Experience

  1. Advent Life SciencesGeneral Partnercurrent2022 — presentLondon, England, United Kingdom
  2. Glycomine Inc.Non Executive Directorcurrent2024 — presentUnited States
  3. Beacon TherapeuticsBoard Observercurrent2024 — present
  4. Pheno Therapeutics LtdNon Executive Directorcurrent2024 — presentEdinburgh, Scotland, United Kingdom
  5. AviadoBioNon Executive Directorcurrent2022 — presentLondon, England, United Kingdom
  6. Amphista Therapeutics LimitedNon Executive Directorcurrent2022 — presentCambridge, England, United Kingdom
  7. Purespring TherapeuticsNon Executive Director2020 — 2022
  8. Forcefield TherapeuticsNon Executive Director2020 — 2022
  9. Anaveon AGNon Executive Director2019 — 2022Switzerland
  10. Syncona LimitedPartner2016 — 2022London, United Kingdom
  11. Syncona LimitedPartner2014 — 2016London, United Kingdom
  12. GYROSCOPE Therapeutics LtdNon Executive Director and Board Observer2019 — 2022
  13. Orbit Biomedical, Inc.Non Executive Director2018 — 2021London / Philadelphia
  14. Freeline Therapeutics LimitedBoard Observer2015 — 2020London
  15. L.E.K. ConsultingAssociate2012 — 2014
  16. Cancer Research UKDoctoral Student2007 — 2011
  17. Max Planck Institute for Molecular GeneticsMaster Student and Research Assistant2006 — 2007

Education

  1. University of CambridgeDoctor of Philosophy (Ph.D.), Oncology2007 — 2011
  2. Freie Universität BerlinGerman Diplom Degree / M.Sc., Biochemistry2002 — 2007

Skills & more

Lifesciences27Genomics14Due Diligence19Biotechnology12Private Equity6Statistics5Biochemistry7Oncology2Management Consulting5Molecular Biology9Valuation5Cell Culture5
+10 moreStrategyBioinformaticsBusiness StrategyCell BiologyGeneticsData AnalysisLife SciencesStrategy ConsultingVenture CapitalFinancial Modeling

Languages English · German

From Dominic's professional profile.

Same school

Shared employers

Investments

Board seats

Amphista TherapeuticsAviadoBioBeacon TherapeuticsGlycomineGyroscope TherapeuticsOrbit BiomedicalPheno Therapeutics

Per the firm's website.

Colleagues at Advent Life Sciences

Network5

Investors connected to Dominic in public investor directories — a warm-intro map.